Notice2021-13119
Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 23, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC). This meeting is partially open to the public. There will be 15 minutes allotted for public comments at the end of the open session from 11:40 a.m., to 11:55 p.m., EDT.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 118 (Wednesday, June 23, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 118 (Wednesday, June 23, 2021)]
[Notices]
[Pages 32934-32935]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-13119]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control (BSC, NCIPC). This
meeting is partially open to the public. There will be 15 minutes
allotted for public comments at the end of the open session from 11:40
a.m., to 11:55 p.m., EDT.
DATES: The meeting will be held on July 29, 2021, from 10:00 a.m. to
12:00 p.m., EDT (OPEN); and from 12:30 p.m., to 4:15 p.m., EDT
(CLOSED).
ADDRESSES: Open Session: Webinar, Atlanta, Georgia. All participants
must register using the link provided to attend the open meeting:
<a href="https://dceproductions.zoom.us/webinar/register/wn_cz3nu0zfsg29fiojefau8q">https://dceproductions.zoom.us/webinar/register/wn_cz3nu0zfsg29fiojefau8q</a>.
Closed Session: Teleconference.
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE, Mailstop S106-9, Atlanta,
[[Page 32935]]
GA 30341, Telephone: (770) 488-3953; Email: <a href="/cdn-cgi/l/email-protection#cd838e849d8e8f9e8e8daea9aee3aaa2bb"><span class="__cf_email__" data-cfemail="87c9c4ced7c4c5d4c4c7e4e3e4a9e0e8f1">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Portions of the meeting as designated above
will be closed to the public in accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of
the Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to Public Law 92-463 (5 U.S.C. App.).
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The BSC, NCIPC makes
recommendations regarding policies, strategies, objectives, and
priorities; reviews progress toward injury prevention goals; and
provides evidence in injury prevention-related research and programs.
The Board also provides advice on the appropriate balance of intramural
and extramural research, and the structure, progress, and performance
of intramural programs. The Board is designed to provide guidance on
extramural scientific program matters, including the: (1) Review of
extramural research concepts for funding opportunity announcements; (2)
conduct of Secondary Peer Review of extramural research grants,
cooperative agreements, and contracts applications received in response
to funding opportunity announcements as they relate to the Center's
programmatic balance and mission; (3) submission of secondary review
recommendations to the Center Director of applications to be considered
for funding support; (4) review of research portfolios, and (5) review
of program proposals.
Matters To Be Considered: The open portion of the agenda will
include discussion on NCIPC Research Priorities for Addressing Adverse
Childhood Experiences. The closed portion of the agenda will focus on
the Secondary Peer Review of extramural research grant applications
received in response to three Notice of Funding Opportunities (NOFOs):
(1) RFA-CE-21-001--``Rigorous Evaluation of Policies for their Impacts
on the Primary Prevention of Multiple Forms of Violence''; (2) RFA-CE-
21-003--``Grants to Support New Investigators in Conducting Research
Related to Preventing Interpersonal Violence Impacting Children and
Youth''; and (3) RFA-CE-21-004--``Research Grants for Preventing
Violence and Violence-Related Injury (R01)''; as well as PHS 2020
Omnibus Solicitation of the NIH, CDC and FDA for Small Business
Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical
Trial Not Allowed). Agenda items are subject to change as priorities
dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-13119 Filed 6-22-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 23, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.